David S Liebeskind1, Reza Jahan2, Raul G Nogueira2, Osama O Zaidat2, Jeffrey L Saver2. 1. From the UCLA Stroke Center (D.S.L., R.J., J.L.S.); Emory University School of Medicine, Atlanta, GA (R.G.N.); and Medical College of Wisconsin, Froedtert Hospital, Milwaukee (O.O.Z.). davidliebeskind@yahoo.com. 2. From the UCLA Stroke Center (D.S.L., R.J., J.L.S.); Emory University School of Medicine, Atlanta, GA (R.G.N.); and Medical College of Wisconsin, Froedtert Hospital, Milwaukee (O.O.Z.).
Abstract
BACKGROUND AND PURPOSE: Collaterals at angiography before endovascular therapy were analyzed to ascertain the effect on a novel end point of successful revascularization without symptomatic hemorrhage in the Solitaire FR With the Intention for Thrombectomy (SWIFT) study. METHODS: Collateral grade (American Society of Interventional and Therapeutic Neuroradiology/Society of Interventional Radiology) on baseline angiography was independently assessed, blind to other data, with statistical analyses delineating the relationship with clinical, laboratory, and imaging parameters. RESULTS: Angiographic data on collaterals were available in 119 of 144 subjects (mean age, 67±12 years; 52% woman; median National Institutes of Health Stroke Scale, 18 [range, 8-28]). Worse collaterals were noted in subjects with elevated baseline blood glucose (P=0.013) and those with elevated baseline systolic blood pressure (P=0.039). Multivariate predictors of partial or worse collaterals included absence of prior hypertension (odds ratio, 4.049, P=0.012), smoking history (odds ratio, 3.822; P=0.013), and higher blood glucose (odds ratio, 1.017; P=0.022). Collaterals were strongly related to Alberta Stroke Program Early CT Score (ASPECTS) at baseline (0-1: median 8 [3-10]; 2-9 [5-10]; 3-9 [7-10]; 4-9 [8-10]; P<0.001) and 24 hours (0-1: median 1 [0-5]; 2-6 [0-10]; 3-8 [0-10]; 4-8 [4-8]; P<0.001). Better collaterals were linked with Thrombolysis in Cerebral Infarction 2b/3 reperfusion (P=0.019), better median National Institutes of Health Stroke Scale at day 7/discharge (P<0.001), and better day 90 modified Rankin Scale (P<0.001). Better collateral grade was associated with successful revascularization without symptomatic hemorrhage, mean 2.3 (95% confidence interval, 2.1-2.5) versus 1.9 (95% confidence interval, 1.7-2.2), P=0.021. CONCLUSIONS: Better collaterals were associated with lower glucose, lower blood pressure, smaller baseline infarcts in SWIFT, and greater likelihood of successful revascularization without hemorrhage and good clinical outcomes. CLINICAL TRIAL REGISTRATION URL: http://www.clinicaltrials.gov. Unique identifier: NCT01054560.
BACKGROUND AND PURPOSE: Collaterals at angiography before endovascular therapy were analyzed to ascertain the effect on a novel end point of successful revascularization without symptomatic hemorrhage in the Solitaire FR With the Intention for Thrombectomy (SWIFT) study. METHODS: Collateral grade (American Society of Interventional and Therapeutic Neuroradiology/Society of Interventional Radiology) on baseline angiography was independently assessed, blind to other data, with statistical analyses delineating the relationship with clinical, laboratory, and imaging parameters. RESULTS: Angiographic data on collaterals were available in 119 of 144 subjects (mean age, 67±12 years; 52% woman; median National Institutes of Health Stroke Scale, 18 [range, 8-28]). Worse collaterals were noted in subjects with elevated baseline blood glucose (P=0.013) and those with elevated baseline systolic blood pressure (P=0.039). Multivariate predictors of partial or worse collaterals included absence of prior hypertension (odds ratio, 4.049, P=0.012), smoking history (odds ratio, 3.822; P=0.013), and higher blood glucose (odds ratio, 1.017; P=0.022). Collaterals were strongly related to Alberta Stroke Program Early CT Score (ASPECTS) at baseline (0-1: median 8 [3-10]; 2-9 [5-10]; 3-9 [7-10]; 4-9 [8-10]; P<0.001) and 24 hours (0-1: median 1 [0-5]; 2-6 [0-10]; 3-8 [0-10]; 4-8 [4-8]; P<0.001). Better collaterals were linked with Thrombolysis in Cerebral Infarction 2b/3 reperfusion (P=0.019), better median National Institutes of Health Stroke Scale at day 7/discharge (P<0.001), and better day 90 modified Rankin Scale (P<0.001). Better collateral grade was associated with successful revascularization without symptomatic hemorrhage, mean 2.3 (95% confidence interval, 2.1-2.5) versus 1.9 (95% confidence interval, 1.7-2.2), P=0.021. CONCLUSIONS: Better collaterals were associated with lower glucose, lower blood pressure, smaller baseline infarcts in SWIFT, and greater likelihood of successful revascularization without hemorrhage and good clinical outcomes. CLINICAL TRIAL REGISTRATION URL: http://www.clinicaltrials.gov. Unique identifier: NCT01054560.
Authors: Jukka Putaala; Tiina Sairanen; Atte Meretoja; Perttu J Lindsberg; Marjaana Tiainen; Ron Liebkind; Daniel Strbian; Sari Atula; Ville Artto; Kirsi Rantanen; Pyry Silvonen; Katja Piironen; Sami Curtze; Olli Häppölä; Satu Mustanoja; Janne Pitkäniemi; Oili Salonen; Heli Silvennoinen; Lauri Soinne; Markku Kuisma; Turgut Tatlisumak; Markku Kaste Journal: Cerebrovasc Dis Date: 2010-11-16 Impact factor: 2.762
Authors: Oh Young Bang; Jeffrey L Saver; Suk Jae Kim; Gyeong-Moon Kim; Chin-Sang Chung; Bruce Ovbiagele; Kwang Ho Lee; David S Liebeskind Journal: Stroke Date: 2011-07-07 Impact factor: 7.914
Authors: Oh Young Bang; Jeffrey L Saver; Suk Jae Kim; Gyeong-Moon Kim; Chin-Sang Chung; Bruce Ovbiagele; Kwang Ho Lee; David S Liebeskind Journal: Stroke Date: 2011-01-13 Impact factor: 7.914
Authors: Jeroen Koerselman; Peter P Th de Jaegere; Marianne C Verhaar; Diederick E Grobbee; Yolanda van der Graaf Journal: Atherosclerosis Date: 2006-05-11 Impact factor: 5.162
Authors: M Rodríguez-Yáñez; M Castellanos; M Blanco; M M García; F Nombela; J Serena; R Leira; I Lizasoain; A Dávalos; J Castillo Journal: Neurology Date: 2006-12-12 Impact factor: 9.910
Authors: O Y Bang; J L Saver; B H Buck; J R Alger; S Starkman; B Ovbiagele; D Kim; R Jahan; G R Duckwiler; S R Yoon; F Viñuela; D S Liebeskind Journal: J Neurol Neurosurg Psychiatry Date: 2007-12-12 Impact factor: 10.154
Authors: Heidi C Roberts; William P Dillon; Anthony J Furlan; Lawrence R Wechsler; Howard A Rowley; Nancy J Fischbein; Randall T Higashida; Carlos Kase; Gregory A Schulz; Ying Lu; Carolyn M Firszt Journal: Stroke Date: 2002-06 Impact factor: 7.914
Authors: J L Saver; R Jahan; E I Levy; T G Jovin; B Baxter; R Nogueira; W Clark; R Budzik; O O Zaidat Journal: Int J Stroke Date: 2012-11-06 Impact factor: 5.266
Authors: Adam de Havenon; David R Haynor; David L Tirschwell; Jennifer J Majersik; Gordon Smith; Wendy Cohen; Jalal B Andre Journal: JAMA Neurol Date: 2017-04-01 Impact factor: 18.302
Authors: I G H Jansen; O A Berkhemer; A J Yoo; J A Vos; G J Lycklama À Nijeholt; M E S Sprengers; W H van Zwam; W J Schonewille; J Boiten; M A A van Walderveen; R J van Oostenbrugge; A van der Lugt; H A Marquering; C B L M Majoie Journal: AJNR Am J Neuroradiol Date: 2016-07-14 Impact factor: 3.825